These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 27997139

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Isotope Labeling Mass Spectrometry to Quantify Endogenous and Exogenous DNA Adducts and Metabolites of 1,3-Butadiene In Vivo.
    Jokipii Krueger CC, Moran E, Tessier KM, Tretyakova NY.
    Chem Res Toxicol; 2023 Aug 21; 36(8):1409-1418. PubMed ID: 37477250
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association of Urinary N7-(1-hydroxyl-3-buten-1-yl) Guanine (EB-GII) Adducts and Butadiene-Mercapturic Acids with Lung Cancer Development in Cigarette Smokers.
    Jokipii Krueger CC, Park SL, Patel Y, Stram DO, Aldrich M, Cai Q, Tretyakova NY.
    Chem Res Toxicol; 2024 Feb 19; 37(2):374-384. PubMed ID: 38315500
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Quantitative analysis of 1,3-butadiene-induced DNA adducts in vivo and in vitro using liquid chromatography electrospray ionization tandem mass spectrometry.
    Tretyakova NYu, Chiang SY, Walker VE, Swenberg JA.
    J Mass Spectrom; 1998 Apr 19; 33(4):363-76. PubMed ID: 9597770
    [Abstract] [Full Text] [Related]

  • 8. Urinary N7-(1-hydroxy-3-buten-2-yl) guanine adducts in humans: temporal stability and association with smoking.
    Jokipii Krueger CC, Madugundu G, Degner A, Patel Y, Stram DO, Church TR, Tretyakova N.
    Mutagenesis; 2020 Feb 13; 35(1):19-26. PubMed ID: 31702786
    [Abstract] [Full Text] [Related]

  • 9. Capillary HPLC-accurate mass MS/MS quantitation of N7-(2,3,4-trihydroxybut-1-yl)-guanine adducts of 1,3-butadiene in human leukocyte DNA.
    Sangaraju D, Villalta P, Goggin M, Agunsoye MO, Campbell C, Tretyakova N.
    Chem Res Toxicol; 2013 Oct 21; 26(10):1486-97. PubMed ID: 23937706
    [Abstract] [Full Text] [Related]

  • 10. High throughput HPLC-ESI(-)-MS/MS methodology for mercapturic acid metabolites of 1,3-butadiene: Biomarkers of exposure and bioactivation.
    Kotapati S, Esades A, Matter B, Le C, Tretyakova N.
    Chem Biol Interact; 2015 Nov 05; 241():23-31. PubMed ID: 25727266
    [Abstract] [Full Text] [Related]

  • 11. HPLC-ESI+-MS/MS analysis of N7-guanine-N7-guanine DNA cross-links in tissues of mice exposed to 1,3-butadiene.
    Goggin M, Loeber R, Park S, Walker V, Wickliffe J, Tretyakova N.
    Chem Res Toxicol; 2007 May 05; 20(5):839-47. PubMed ID: 17455958
    [Abstract] [Full Text] [Related]

  • 12. Quantitative high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry analysis of the adenine-guanine cross-links of 1,2,3,4-diepoxybutane in tissues of butadiene-exposed B6C3F1 mice.
    Goggin M, Anderson C, Park S, Swenberg J, Walker V, Tretyakova N.
    Chem Res Toxicol; 2008 May 05; 21(5):1163-70. PubMed ID: 18442269
    [Abstract] [Full Text] [Related]

  • 13. Intra- and Inter-Species Variability in Urinary N7-(1-Hydroxy-3-buten-2-yl)guanine Adducts Following Inhalation Exposure to 1,3-Butadiene.
    Erber L, Goodman S, Wright FA, Chiu WA, Tretyakova NY, Rusyn I.
    Chem Res Toxicol; 2021 Nov 15; 34(11):2375-2383. PubMed ID: 34726909
    [Abstract] [Full Text] [Related]

  • 14. N6-(2-Deoxy-d- erythro-pentofuranosyl)-2,6-diamino-3,4-dihydro-4-oxo-5- N-(2-hydroxy-3-buten-1-yl)-formamidopyrimidine Adducts of 1,3-Butadiene: Synthesis, Structural Identification, and Detection in Human Cells.
    Groehler AS, Najjar D, Pujari SS, Sangaraju D, Tretyakova NY.
    Chem Res Toxicol; 2018 Sep 17; 31(9):885-897. PubMed ID: 30016111
    [Abstract] [Full Text] [Related]

  • 15. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
    Blair IA, Oe T, Kambouris S, Chaudhary AK.
    Res Rep Health Eff Inst; 2000 Mar 17; (92):151-90; discussion 211-9. PubMed ID: 10925841
    [Abstract] [Full Text] [Related]

  • 16. Bis-butanediol-mercapturic acid (bis-BDMA) as a urinary biomarker of metabolic activation of butadiene to its ultimate carcinogenic species.
    Kotapati S, Sangaraju D, Esades A, Hallberg L, Walker VE, Swenberg JA, Tretyakova NY.
    Carcinogenesis; 2014 Jun 17; 35(6):1371-8. PubMed ID: 24531806
    [Abstract] [Full Text] [Related]

  • 17. Macromolecular adducts of butadiene.
    Tretyakova NYu, Lin YP, Upton PB, Sangaiah R, Swenberg JA.
    Toxicology; 1996 Oct 28; 113(1-3):70-6. PubMed ID: 8901884
    [Abstract] [Full Text] [Related]

  • 18. Quantitative analysis of trihydroxybutyl mercapturic acid, a urinary metabolite of 1,3-butadiene, in humans.
    Kotapati S, Matter BA, Grant AL, Tretyakova NY.
    Chem Res Toxicol; 2011 Sep 19; 24(9):1516-26. PubMed ID: 21749114
    [Abstract] [Full Text] [Related]

  • 19. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.
    Koc H, Tretyakova NY, Walker VE, Henderson RF, Swenberg JA.
    Chem Res Toxicol; 1999 Jul 19; 12(7):566-74. PubMed ID: 10409395
    [Abstract] [Full Text] [Related]

  • 20. NanoHPLC-nanoESI(+)-MS/MS quantitation of bis-N7-guanine DNA-DNA cross-links in tissues of B6C3F1 mice exposed to subppm levels of 1,3-butadiene.
    Sangaraju D, Goggin M, Walker V, Swenberg J, Tretyakova N.
    Anal Chem; 2012 Feb 07; 84(3):1732-9. PubMed ID: 22220765
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.